Shinji Kobuchi

Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Locally Advanced

Tyrosine Kinase

Metastatic Colorectal Cancer

Circulating Tumor

Top Venues

The Journal of pharmacology and experimental therapeutics

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Shinji Kobuchi, Mayuka Arimoto, Yukako Ito
Translational pharmacokinetic-toxicodynamic model of myelosuppression for dose optimization in combination chemotherapy of capecitabine and oxaliplatin from rats to humans . The Journal of pharmacology and experimental therapeutics (2024)
Shinji Kobuchi, Mayuka Arimoto, Yukako Ito
Translational Pharmacokinetic-Toxicodynamic Model of Myelosuppression for Dose Optimization in Combination Chemotherapy of Capecitabine and Oxaliplatin from Rats to Humans. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Yukako Ito, Shinji Kobuchi, Amiri Kawakita, Kazuki Tosaka, Yume Matsunaga, Shoma Yoshioka, Shizuka Jonan, Kikuko Amagase, Katsunori Hashimoto, Mitsuro Kanda, Takuya Saito, Hayao Nakanishi
Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer. Cancers 15 (22) (2023)
Tetsuo Hayakawa, Ken-Ichiro Kato, Shinji Kobuchi, Kaede Kataoka, Toshiyuki Sakaeda
Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Shinji Kobuchi, Naoya Kanda, Taichi Okumi, Yuma Kano, Himawari Tachi, Yukako Ito, Toshiyuki Sakaeda
Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant Staphylococcus aureus agents using a rat model of sepsis. Xenobiotica; the fate of foreign compounds in biological systems 52 (6) (2022)
Shinji Kobuchi, Miyu Kai, Yukako Ito
Population Pharmacokinetic Model-Based Evaluation of Intact Oxaliplatin in Rats with Acute Kidney Injury. Cancers 13 (24) (2021)
Shinji Kobuchi, Atsushi Shigemura, Yukako Ito, Toshiyuki Sakaeda
A validated LC-MS/MS method for the low-level determination of pemafibrate, a novel SPPARMα, in plasma. Bioanalysis 12 (10) (2020)
Shinji Kobuchi, Teruhiko Kabata, Koki Maeda, Yukako Ito, Toshiyuki Sakaeda
Pharmacokinetics of Macrolide Antibiotics and Transport into the Interstitial Fluid: Comparison among Erythromycin, Clarithromycin, and Azithromycin. Antibiotics (Basel, Switzerland) 9 (4) (2020)
Shinji Kobuchi, Mako Akutagawa, Yukako Ito, Toshiyuki Sakaeda
Association between the pharmacokinetics of capecitabine and the plasma dihydrouracil to uracil ratio in rat: A surrogate biomarker for dihydropyrimidine dehydrogenase activity. Biopharmaceutics & drug disposition 40 (1) (2019)
Keiko Nakao, Shinji Kobuchi, Shuhei Marutani, Ayano Iwazaki, Akihiro Tamiya, Shunichi Isa, Kyoichi Okishio, Masaki Kanazu, Motohiro Tamiya, Tomonori Hirashima, Kimie Imai, Toshiyuki Sakaeda, Shinji Atagi
Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer. Scientific reports 9 (1) (2019)